Loxo Oncology, Inc.
SEC CIK 1581720 · LOXO · last insider filing 2019-02-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mayleben Timothy M | Director | filed 2015 - 2019 |
| Elms Steve | Director | filed 2014 - 2019 |
| Fuhrman Alan | Director | filed 2015 - 2019 |
| Kunkel Lori Anne | Director | filed 2014 - 2019 |
| Flaherty Keith T. | Director | filed 2014 - 2019 |
| Naider Avi Z. | Director | filed 2014 - 2019 |
| Bilenker Joshua H. | Director · President & CEO | filed 2014 - 2019 |
| Harr Steve | Director | filed 2016 - 2019 |
| Isaly Samuel D | Director | filed 2014 - 2017 |
| Orbimed Advisors LLC | Director | filed 2014 - 2017 |
| Bonita David P | Director | filed 2014 - 2017 |
| Orbimed Capital GP V LLC | Director | filed 2014 - 2017 |
| Barrett M James | Director | filed 2014 - 2015 |
| Goldstein DOV A MD | Director · CFO and Treasurer | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Burstein Jennifer | Vice President of Finance | filed 2015 - 2019 |
| Van Naarden Jacob | Chief Operating Officer | filed 2016 - 2019 |
| Nanda Nisha | Chief Development Officer | filed 2019 - 2019 |
| Low Jennifer A. | EVP, Development & Research | filed 2014 - 2014 |
| Moyer Mikel Paul | Chief Scientific Officer | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.